MetaCap

Evolus Statistics

NASDAQ: EOLSHealth CareBiotechnology: Pharmaceutical PreparationsUSD

6.52-0.48 (-6.86%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Evolus by the numbers

Evolus has a market capitalization of $431.5 million based on 66.19M shares outstanding. With trailing EPS of $-0.48, Evolus is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 12.4% below its 50-day average and 1.5% above its 200-day average.

Average daily trading volume is 925.77K shares, or about $6.0 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

EOLS valuation vs. peer median

EOLS compared with the median of 8 peer companies
MetricEOLSPeer medianDifference
Market cap$431.55M$434.02M-1%
Avg. volume925.77K1.14M-19%

Peer median across 8 companies: INDP, AQST, ARVN, PRTA, CAPR, LYEL, CTMX, CRMD.

Valuation

Market cap
$431.55M
Price / sales (latest FY)
1.45
EPS (TTM)
$-0.48

Price and trading

Previous close
7.00
Open
6.79
Day range
6.50 – 7.19
52-week range
3.86 – 9.31
52-week change
-4.82%
Beta
—
Volume
813.65K

Dividends and events

Annual dividend
None

Additional statistics

Market Cap
431.55M
Forward Pe
22.68
Eps
-0.48
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
9.31
Week52 Low
3.86
Avg Volume
925.77K
Shares Outstanding
66.19M
Ma50
7.45
Ma200
6.42
Earnings Date
Nov 4, 2026
Pct From52w High
-29.97%
Pct From52w Low
68.91%

Related